Reference ranges for serum IGF-1 and IGFBP-3 levels in Chinese children during childhood and adolescence
- PMID: 20051649
- DOI: 10.1507/endocrj.k09e-200
Reference ranges for serum IGF-1 and IGFBP-3 levels in Chinese children during childhood and adolescence
Abstract
Serum levels of insulin-like growth factor-1(IGF-1) and insulin-like growth factor binding protein-3(IGFBP-3) reflect endogenous growth hormone secretion, and serum IGF-1 and IGFBP-3 values should be ethnic-specific, thus we established the reference ranges for serum IGF-1 and IGFBP-3 in Chinese children aged 6-18 yr according to age, sex, puberty stage and BMI. The study was included 837 children (age 6-18 yr, 416 boys and 421 girls) from different schools in Daqing, Beijing and Shanghai. Serum IGF-1 and IGFBP-3 were determined by a chemiluminescent assay system (IMMULITE 1000). The results show that IGF1 reached peak levels at around 13 yr in boys and 11 yr in girls while IGFBP-3 peaked at 14 yr in boys, and 11 yr in girls. Both IGF-1 and IGFBP-3 were at platform or decreased slightly after these ages. At each corresponding age, IGF-1 levels tended to be higher in boys compared to girls, while girls had higher IGFBP-3 levels than boys. A model for calculation of standard deviation scores of IGF-1 and IGFBP3 according to age, sex and pubertal stage was established. These normative data should facilitate child care, growth monitoring, clinical diagnosis and to follow up on GH treatment.
Similar articles
-
Serum IGF-I and IGFBP-3 levels of Turkish children during childhood and adolescence: establishment of reference ranges with emphasis on puberty.Horm Res. 2006;65(2):96-105. doi: 10.1159/000091301. Epub 2006 Feb 3. Horm Res. 2006. PMID: 16462144
-
Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence.J Clin Endocrinol Metab. 2005 Mar;90(3):1420-7. doi: 10.1210/jc.2004-0812. Epub 2004 Dec 14. J Clin Endocrinol Metab. 2005. PMID: 15598696
-
Establishment of reference serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels of Tunisian children during childhood and adolescence.J Endocrinol Invest. 2009 Sep;32(8):671-6. doi: 10.1007/BF03345739. Epub 2009 Apr 7. J Endocrinol Invest. 2009. PMID: 19494704
-
Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.J Clin Endocrinol Metab. 1995 Aug;80(8):2534-42. doi: 10.1210/jcem.80.8.7543116. J Clin Endocrinol Metab. 1995. PMID: 7543116
-
Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents.Clin Biochem. 2012 Jan;45(1-2):16-21. doi: 10.1016/j.clinbiochem.2011.10.003. Epub 2011 Oct 12. Clin Biochem. 2012. PMID: 22032863
Cited by
-
Relationship of insulin-like growth factor 1 and bone parameters in 7-15 years old apparently, healthy Indian children.Indian J Endocrinol Metab. 2015 Nov-Dec;19(6):770-4. doi: 10.4103/2230-8210.167549. Indian J Endocrinol Metab. 2015. PMID: 26693426 Free PMC article.
-
Serum insulin-like growth factor-1 measurements in dogs: performance characteristics of an automated assay and study of some sources of variation.Can J Vet Res. 2011 Oct;75(4):312-6. Can J Vet Res. 2011. PMID: 22468030 Free PMC article. Clinical Trial.
-
Reference ranges for an automated chemiluminescent assay for serum insulin-like growth factor I (IGF-I) in a large population of healthy adults from Buenos Aires.J Endocrinol Invest. 2015 Sep;38(9):951-6. doi: 10.1007/s40618-015-0265-z. Epub 2015 Mar 5. J Endocrinol Invest. 2015. PMID: 25740070
-
Expanding the clinical phenotype of IARS2-related mitochondrial disease.BMC Med Genet. 2018 Nov 12;19(1):196. doi: 10.1186/s12881-018-0709-3. BMC Med Genet. 2018. PMID: 30419932 Free PMC article.
-
Serum prolactin levels were positively related to metabolic indexes and disorders in male obese patients.Endocrine. 2024 Jun;84(3):1097-1107. doi: 10.1007/s12020-024-03743-1. Epub 2024 Feb 24. Endocrine. 2024. PMID: 38396200
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous